Candel Therapeutics, Inc.
CADL$9.27▲ 5.28% 24h
$9.27
-$0.322(-3.36%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$678.63M
P/E ratio
—
EPS (diluted)
$-0.72
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$125,000
Net income
$-38.18M
Net margin
-30545.6%
Gross margin
—
Dividends & financials
Candel Therapeutics, Inc. (CADL) reported revenue of $125,000 and net income of $-38.18M, or $-0.72 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.
